Mexiletine and Propranolol Interaction

Understanding the Mexiletine and Propranolol Interaction

FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Mexiletine belongs to the Class IB Antiarrhythmic class and Propranolol belongs to the Non-Selective Beta-Blocker class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: These two heart medicines can be used together to help control irregular heartbeats without changing the heart's electrical timing. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Mexiletine has 14 total documented interactions on file in this dataset, and Propranolol has 44. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor may combine these drugs to better manage your heart rhythm, but they will likely monitor your heart's activity. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Mexiletine or Propranolol based on a web page, speak with your prescriber or pharmacist before making any change.